Global Corneal Transplant Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Type;

Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Limbal Stem Cell Transplant and Others.

By Indication;

Fungal Corneal Ulcer, Bullous Keratopathy, Keratoconus, Keratitis, Corneal Stromal Dystrophies and Others.

By Graft Type;

Partial Thickness Grafts (Lamellar), and Full Thickness Grafts (Penetrating).

By Surgery Type;

Conventional Surgery, and Laser-Assisted Surgery.

By End User;

Hospital, Eye Clinics and Others.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn103826752 Published Date: March, 2025 Updated Date: April, 2025

Introduction

Global Corneal Transplant Market (USD Million), 2021 - 2031

In the year 2024, the Global Corneal Transplant Market was valued at USD 560.15 million. The size of this market is expected to increase to USD 911.32 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 7.2%.

The global corneal transplant market is experiencing significant growth and evolution, driven by a multitude of factors that are reshaping the landscape of ophthalmic care. This growth is attributed to several key factors, including the rising prevalence of eye diseases such as keratoconus, infectious keratitis, and other corneal conditions, which have led to an increased demand for minimally invasive surgical procedures and a surge in awareness regarding corneal transplants. Additionally, the market segmentation based on indications encompasses a wide range of conditions, including fungal corneal ulcer, bullous keratopathy, keratoconus, keratitis, corneal stromal dystrophies, and others, reflecting the diverse spectrum of ophthalmic disorders that are driving the demand for corneal transplant procedures. The market's growth is further fueled by technological advancements and the increasing adoption of innovative treatment modalities, such as corneal implants, to address the escalating prevalence of eye diseases and vision impairment globally.

The corneal transplant market is characterized by a comprehensive range of surgical techniques, including penetrating keratoplasty, Descemet Membrane Endothelial Keratoplasty (DMEK), Descemet Stripping Endothelial Keratoplasty (DSEK), corneal limbal stem cell transplant, and others. These advanced procedures, coupled with the growing demand for patient-specific treatments and the rising burden of chronic disorders, have significantly influenced the expansion of the corneal transplant market. Moreover, the market's trajectory is shaped by the increasing necessity for treatment modalities like corneal implants, particularly in the context of the escalating incidence of Fuchs dystrophy and the global aging population. As the corneal transplant market continues to evolve, it is essential to recognize the pivotal role it plays in addressing the global issue of corneal blindness, which ranks as the third most prevalent cause of blindness worldwide. The market's growth trajectory reflects the critical importance of advancing ophthalmic care to meet the evolving needs of patients and healthcare systems worldwide.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Type
    2. Market Snapshot, By Indication
    3. Market Snapshot, By Graft Type
    4. Market Snapshot, By Surgery Type
    5. Market Snapshot, By End User
    6. Market Snapshot, By Region
  4. Global Corneal Transplant Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Advancements in Surgical Procedures and Instruments

        2. Growing Prevalence of Ophthalmic Diseases

        3. Technological Innovations in Eye Banking and Storage

        4. Increasing Focus on Public Awareness and Education

      2. Restraints
        1. Limited Availability of Donor Corneas

        2. Regulatory Challenges and Compliance

        3. Risks Associated with Corneal Transplantation

        4. Financial Barriers and Healthcare Infrastructure

      3. Opportunities
        1. Technological Advancements in Treatment Facilities

        2. Increasing Awareness and Education Initiatives

        3. Growing Emphasis on Minimally Invasive Surgical Techniques

        4. Increasing Prevalence of Ophthalmic Diseases

    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Corneal Transplant Market, By Type, 2021 - 2031 (USD Million)
      1. Penetrating Keratoplasty
      2. Endothelial Keratoplasty
      3. Descemet Stripping Automated Endothelial Keratoplasty
      4. Corneal Limbal Stem Cell Transplant
    2. Global Corneal Transplant Market, By Indication, 2021 - 2031 (USD Million)
      1. Fungal Corneal Ulcer
      2. Bullous Keratopathy
      3. Keratoconus
      4. Keratitis
      5. Corneal Stromal Dystrophies
    3. Global Corneal Transplant Market, By Graft Type, 2021 - 2031 (USD Million)
      1. Partial Thickness Grafts (Lamellar)
      2. Full Thickness Grafts (Penetrating)
    4. Global Corneal Transplant Market, By Surgery Type, 2021 - 2031 (USD Million)
      1. Conventional Surgery
      2. Laser-Assisted Surgery
    5. Global Corneal Transplant Market, By End User, 2021 - 2031 (USD Million)
      1. Hospital
      2. Eye Clinics
    6. Global Corneal Transplant Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Cryolife, Inc.
      2. Exactech, Inc.
      3. Köhler Gmbh
      4. Lifeline Scientific
      5. Lifecell Corporation
      6. Medtronic
  7. Analyst Views
  8. Future Outlook of the Market